To investigate whether impaired MHC-I-β2M complex was involved in AD pathology, we investigated synaptic MHC-I levels in AD brains because functional neuronal MHC-I is mainly localized to the synapses [26, 27]. This evidence concerns the gene B2M and Alzheimer disease.